熱門資訊> 正文
Laser Photonics从美国制药商获得105万美元订单
2026-08-24 20:41
- Laser Photonics (LASE) on Monday said its subsidiary, CMS Laser, has received a purchase order valued at about $1.05M from a U.S.-based pharmaceutical company for a TD-70 high-speed pharmaceutical tablet drilling system.
- In addition to this order, Laser Photonics said it intends to expand its investment in CMS Laser and its technology platform as part of a broader strategy to support the subsidiary's growth and continued product development.
- Press release
More on Laser Photonics
- Laser Photonics secures first REXA order for CleanTech laser system
- Laser Photonics regains Nasdaq compliance as 10-Q delay issue resolved
- Historical earnings data for Laser Photonics
- Financial information for Laser Photonics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
